Opko Health Inc (OPK)

1,214
-22(-1.78%)
  • Volume:
    54,978
  • Bid/Ask:
    1,215/1,218
  • Day's Range:
    1,212 - 1,234
  • Type:Equity
  • Market:Israel
  • ISIN:US68375N1037
  • S/N:01129543

OPK Overview

Prev. Close
1,236
Day's Range
1,212-1,234
Revenue
-
Open
1,234
52 wk Range
1,092-2,043
EPS
-
Volume
54,978
Market Cap
8.18B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
396,784
P/E Ratio
32.32
Beta
-
1-Year Change
-20.97%
Shares Outstanding
681,099,362
Next Earnings Date
-
What is your sentiment on Opko Health Inc?
or
Vote to see community's results!

Opko Health Inc Company Profile

Employees
5269

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company’s Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellSell
Technical IndicatorsStrong BuyStrong SellStrong SellStrong SellNeutral
SummaryBuyStrong SellStrong SellStrong SellNeutral
  • stock manipulation. OPK is worthless, the hedge funds keeps shorting....
    0
    • going up for
      0
      • Ante, you are wrong again. OPK has nowhere to go. OPK is not suitable for purchase. It is only suitable for short selling.
        0
        • OPK falls again today. if you buy in now, you lose.
          0
          • hi Ray ... I am full in. parchy
            0
            • where are the buyers? they did not say at anything for long time, why did they shut up after OPK fell? I believe they will yell loud when OPK goes up. let's see
              0
              • OPK missed so many chance to make profits because the company has very bad management team.
                0
                • Ante Parcina yo are such a big loser here. your investment strategy is so bad. As I said it before, never buy OPK if the CEO still in the company.
                  0
                  • omg
                    1
                    • that changes nothing when you come in. OPK is still low
                      1
                      • OPKO my old love, since Monday I am comming in!
                        1
                        • COVID-19 cases increase everywhere, but OPK seems get nothing rewards.
                          0
                          • lots of buyers listened to me & sold OPK. OPK has no future!
                            0
                            • when OPK starts to move up, that means we should ready for another short sell season. smart people won't hold OPK.
                              0
                              • what's ur price for sell it b4 the short?
                                0
                            • price start to go up
                              0
                              • Stay away from this s c a m stock!!
                                0
                                • Thank you CEO for knocking down OPK. All short sellers are very happy & rich 👍
                                  0
                                  • the buyers lost money here because they trust the CEO of OPK.
                                    0
                                    • have to confese I lost money on OPKO. That is stock market
                                      1
                                      • Ante is a real loser! 🤣
                                        0
                                        • when OPK dropped, all buyers disappeared. why???
                                          0
                                          • Yes, if you live in paradise, you may see 20 dollars or even 30 dollars. 👼
                                            0
                                            • hope it will go back to 5
                                              0
                                          • 15$ itS juste station...like bus station. destination is 20$+
                                            0
                                            • hahaha....🙂😀😂🤣... $15? this is the most funniest joke I have ever heard.
                                              0
                                              • ray you donT have a better job then to speak with me...lol. ladt time I said 12$ spike price for OPKO . TAHIS TIME 15$ AT LEAST.Releax and let u see
                                                0
                                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.